• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤浸润 B 细胞:其在肿瘤微环境中的双重作用机制。

Tumor-infiltrating B cells: Their dual mechanistic roles in the tumor microenvironment.

机构信息

School of Chinese Classics, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.

Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou 510006, China.

出版信息

Biomed Pharmacother. 2024 Oct;179:117436. doi: 10.1016/j.biopha.2024.117436. Epub 2024 Sep 12.

DOI:10.1016/j.biopha.2024.117436
PMID:39270540
Abstract

The occurrence and development of tumors are closely associated with abnormalities in the immune system's structure and function, with tumor immunotherapy being intricately linked to the tumor microenvironment (TME). Early studies on lymphocytes within the TME primarily concentrated on T cells. However, as research has advanced, the multifaceted roles of tumor-infiltrating B cells (TIL-Bs) in tumor immunity, encompassing both anti-tumor and pro-tumor effects, have garnered increasing attention. This paper explored the composition of the TME and the biological characteristics of TIL-Bs, investigating the dual roles within the TME to offer new insights and strategies for tumor immunotherapy.

摘要

肿瘤的发生和发展与免疫系统结构和功能的异常密切相关,肿瘤免疫治疗与肿瘤微环境(TME)密切相关。早期对 TME 中的淋巴细胞的研究主要集中在 T 细胞上。然而,随着研究的进展,肿瘤浸润 B 细胞(TIL-Bs)在肿瘤免疫中的多方面作用,包括抗肿瘤和促肿瘤作用,引起了越来越多的关注。本文探讨了 TME 的组成和 TIL-Bs 的生物学特性,研究了 TME 中的双重作用,为肿瘤免疫治疗提供了新的见解和策略。

相似文献

1
Tumor-infiltrating B cells: Their dual mechanistic roles in the tumor microenvironment.肿瘤浸润 B 细胞:其在肿瘤微环境中的双重作用机制。
Biomed Pharmacother. 2024 Oct;179:117436. doi: 10.1016/j.biopha.2024.117436. Epub 2024 Sep 12.
2
Prognostic Landscape of Tumor-Infiltrating T and B Cells in Human Cancer.肿瘤浸润 T 和 B 细胞在人类癌症中的预后景观。
Front Immunol. 2022 Jan 4;12:731329. doi: 10.3389/fimmu.2021.731329. eCollection 2021.
3
The Tumor Microenvironment in the Response to Immune Checkpoint Blockade Therapies.肿瘤微环境对免疫检查点阻断治疗的反应。
Front Immunol. 2020 May 7;11:784. doi: 10.3389/fimmu.2020.00784. eCollection 2020.
4
Tumor-infiltrating B cells affect the progression of oropharyngeal squamous cell carcinoma via cell-to-cell interactions with CD8 T cells.肿瘤浸润 B 细胞通过与 CD8 T 细胞的细胞间相互作用影响口咽鳞状细胞癌的进展。
J Immunother Cancer. 2019 Oct 17;7(1):261. doi: 10.1186/s40425-019-0726-6.
5
Potential role of tumor-infiltrating T-, B-lymphocytes, tumor-associated macrophages and IgA-secreting plasma cells in long-term survival in the rectal adenocarcinoma patients.肿瘤浸润性 T、B 淋巴细胞、肿瘤相关巨噬细胞和 IgA 分泌浆细胞在直肠腺癌患者长期生存中的潜在作用。
Life Sci. 2021 Dec 1;286:120052. doi: 10.1016/j.lfs.2021.120052. Epub 2021 Oct 14.
6
Hijacked Immune Cells in the Tumor Microenvironment: Molecular Mechanisms of Immunosuppression and Cues to Improve T Cell-Based Immunotherapy of Solid Tumors.肿瘤微环境中被劫持的免疫细胞:免疫抑制的分子机制及改善实体瘤 T 细胞为基础免疫治疗的线索。
Int J Mol Sci. 2021 May 27;22(11):5736. doi: 10.3390/ijms22115736.
7
Targeted Anti-Tumor Immunotherapy Using Tumor Infiltrating Cells.肿瘤浸润细胞的靶向抗肿瘤免疫治疗。
Adv Sci (Weinh). 2021 Nov;8(22):e2101672. doi: 10.1002/advs.202101672. Epub 2021 Oct 18.
8
Antigen-Presenting Intratumoral B Cells Affect CD4 TIL Phenotypes in Non-Small Cell Lung Cancer Patients.肿瘤内抗原呈递细胞影响非小细胞肺癌患者 CD4 TIL 表型。
Cancer Immunol Res. 2017 Oct;5(10):898-907. doi: 10.1158/2326-6066.CIR-17-0075. Epub 2017 Aug 28.
9
Characterization and Differentiation of the Tumor Microenvironment (TME) of Orthotopic and Subcutaneously Grown Head and Neck Squamous Cell Carcinoma (HNSCC) in Immunocompetent Mice.原位和皮下种植的免疫活性小鼠头颈部鳞状细胞癌(HNSCC)肿瘤微环境(TME)的特征和分化。
Int J Mol Sci. 2020 Dec 29;22(1):247. doi: 10.3390/ijms22010247.
10
Advancements in tumor-infiltrating lymphocytes: Historical insights, contemporary milestones, and future directions in oncology therapy.肿瘤浸润淋巴细胞的进展:肿瘤治疗学中的历史洞察、当代里程碑和未来方向。
Crit Rev Oncol Hematol. 2024 Oct;202:104471. doi: 10.1016/j.critrevonc.2024.104471. Epub 2024 Aug 8.

引用本文的文献

1
The distinct landscape of tumor immune microenvironment in homologous recombination deficient cancers.同源重组缺陷型癌症中独特的肿瘤免疫微环境格局。
Biomark Res. 2025 Aug 20;13(1):108. doi: 10.1186/s40364-025-00814-x.
2
Immunopharmacology of gastric cancer-deciphering immune cell subset responses and nanoparticle-mediated targeting.胃癌的免疫药理学——解析免疫细胞亚群反应与纳米颗粒介导的靶向作用
Front Pharmacol. 2025 May 19;16:1611234. doi: 10.3389/fphar.2025.1611234. eCollection 2025.
3
A systemic review on leptin's role in defining cancer: special emphasis on immunomodulation, inflammation, and therapeutic interventions.
关于瘦素在癌症定义中的作用的系统评价:特别强调免疫调节、炎症和治疗干预。
Genes Immun. 2025 May 15. doi: 10.1038/s41435-025-00333-7.
4
Identification and validation of molecular subtypes and prognostic models in patients with kidney cancer based on differential genes based on B cells: a multiomics analysis.基于B细胞差异基因的肾癌患者分子亚型及预后模型的鉴定与验证:一项多组学分析
BMC Cancer. 2025 Mar 28;25(1):559. doi: 10.1186/s12885-025-13923-5.
5
The Immune Environment in Colorectal Adenoma: A Systematic Review.结直肠腺瘤中的免疫环境:一项系统综述
Biomedicines. 2025 Mar 12;13(3):699. doi: 10.3390/biomedicines13030699.
6
Development and validation of an immune signature-based risk model for prognostic assessment in melanoma.基于免疫特征的黑色素瘤预后评估风险模型的开发与验证
Sci Rep. 2025 Mar 17;15(1):9117. doi: 10.1038/s41598-025-90917-0.
7
Microbiome Differences in Colorectal Cancer Patients and Healthy Individuals: Implications for Vaccine Antigen Discovery.结直肠癌患者与健康个体的微生物组差异:对疫苗抗原发现的启示
Immunotargets Ther. 2024 Dec 13;13:749-774. doi: 10.2147/ITT.S486731. eCollection 2024.